BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27618033)

  • 1. Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma.
    Lorente L; Rodriguez ST; Sanz P; Pérez-Cejas A; Padilla J; Díaz D; González A; Martín MM; Jiménez A; Barrera MA
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study.
    Lorente L; Martín MM; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; Borreguero-León JM
    PLoS One; 2015; 10(3):e0121739. PubMed ID: 25822281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of caspase-cleaved cytokeratin-18 and mortality are associated in severe septic patients: pilot study.
    Lorente L; Martín MM; González-Rivero AF; Ferreres J; Solé-Violán J; Labarta L; Díaz C; Jiménez A; Borreguero-León JM
    PLoS One; 2014; 9(10):e109618. PubMed ID: 25290885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum caspase-cleaved cytokeratin-18 levels and outcomes after aneurysmal subarachnoid hemorrhage.
    Yuan ZG; Wang JL; Jin GL; Yu XB; Li JQ; Qiu TL; Dai RX
    J Neurol Sci; 2015 Dec; 359(1-2):298-304. PubMed ID: 26671131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantation.
    Lorente L; Rodriguez ST; Sanz P; González-Rivero AF; Pérez-Cejas A; Padilla J; Díaz D; González A; Martín MM; Jiménez A; Cerro P; Portero J; Barrera MA
    Expert Rev Mol Diagn; 2019 Jul; 19(7):635-640. PubMed ID: 31084510
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictive value of serum caspase-cleaved cytokeratin-18 concentrations after acute intracerebral hemorrhage.
    Gu SJ; Lu M; Xuan HF; Chen XZ; Dong WF; Yan XF; Si Y; Gao GL; Hu DX; Miao JQ
    Clin Chim Acta; 2016 Jan; 452():124-8. PubMed ID: 26569346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher serum caspase-cleaved cytokeratin-18 levels during the first week of sepsis diagnosis in non-survivor patients.
    Lorente L; Martín MM; Pérez-Cejas A; López RO; Ferreres J; Solé-Violán J; Labarta L; Díaz C; Palmero S; Buitrago M; Jiménez A; Borreguero-León JM
    Clin Chem Lab Med; 2017 Aug; 55(10):1621-1629. PubMed ID: 28282291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute Elevation of Plasma Level of Caspase-Cleaved Cytokeratin-18 is Associated with Hemorrhagic Transformation and Functional Outcome in Ischemic Stroke.
    Molnar T; Borocz K; Berki T; Szapary L; Szolics A; Janszky J; Illes Z; Csecsei P
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):719-727. PubMed ID: 30528602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
    Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
    J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum levels of caspase-cleaved cytokeratin-18 and early mortality in patients with severe spontaneous intracerebral hemorrhage.
    Lorente L; Martín MM; Pérez-Cejas A; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    BMC Neurosci; 2018 Apr; 19(1):23. PubMed ID: 29661155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular Carcinoma.
    Lorente L; Rodriguez ST; Sanz P; Abreu-González P; Díaz D; Moreno AM; Borja E; Martín MM; Jiménez A; Barrera MA
    Int J Mol Sci; 2016 Apr; 17(4):500. PubMed ID: 27058525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortality.
    Lorente L; Martín MM; Pérez-Cejas A; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    BMC Neurol; 2018 Mar; 18(1):32. PubMed ID: 29573748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-Cleaved Cytokeratin 18 Fragment M30 as a Potential Biomarker of Macrovascular Invasion in Hepatocellular Carcinoma.
    Elalfy H; Besheer T; Arafa MM; El-Hussiny MA; El Latif MA; Alsayed SAM
    J Gastrointest Cancer; 2018 Sep; 49(3):260-267. PubMed ID: 28361205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum caspase 3 levels are associated with early mortality in severe septic patients.
    Lorente L; Martín MM; Ferreres J; Solé-Violán J; Labarta L; Díaz C; Jiménez A; Borreguero-León JM
    J Crit Care; 2016 Aug; 34():103-6. PubMed ID: 27288619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B.
    Eren F; Yilmaz Y; Kose S; Ozdemir FT; Yonal O; Kurt R; Ozdogan O; Avsar E
    Clin Chim Acta; 2010 Dec; 411(23-24):2029-32. PubMed ID: 20807521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma.
    Lorente L
    World J Gastroenterol; 2018 Oct; 24(37):4230-4242. PubMed ID: 30310256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum soluble CD40L levels previously to liver transplantation in patients with hepatocellular carcinoma are associated with mortality at one year.
    Lorente L; Rodriguez ST; Sanz P; Pérez-Cejas A; Padilla J; Díaz D; González A; Martín MM; Jiménez A; Barrera MA
    J Crit Care; 2018 Feb; 43():316-320. PubMed ID: 29020665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum total antioxidant capacity prior to liver transplantation for hepatocellular carcinoma is associated with 1-year liver transplantation survival.
    Lorente L; Rodriguez ST; Sanz P; Pérez-Cejas A; Abreu-González P; Padilla J; Díaz D; González A; Martín MM; Jiménez A; Cerro P; Barrera MA
    J Int Med Res; 2018 Jul; 46(7):2641-2649. PubMed ID: 29911482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Serum Melatonin Levels Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma are Associated with Lower Survival after Liver Transplantation.
    Lorente L; Rodriguez ST; Sanz P; Abreu-González P; González-Rivero AF; Pérez-Cejas A; Padilla J; Díaz D; González A; Martín MM; Jiménez A; Cerro P; Portero J; Barrera MA
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nesfatin-1 and caspase-cleaved cytokeratin-18: Promising biomarkers for Alzheimer's disease?
    Alpua M; Kisa U
    Bratisl Lek Listy; 2019; 120(4):295-298. PubMed ID: 31023053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.